Some pharmacological properties of murexine (urocanoylcholine).

Abstract	Murexine (urocanoylcholine, [2-beta-imidazol-4(5)-ylacryloyloxyethyl] trimethylammonium bromide) has been shown to possess ganglion stimulating and neuromuscular blocking actions in cat, dog and rat. The blockade has been shown to be of the depolarizing type both on the basis of the resemblance of the pharmacological properties of the substance to that of known depolarizing blocking agents, and also directly by recording the depolarization produced in the endplate region of the gracilis muscle of the rat.
Authors	M J KEYL, V P WHITTAKER
Journal	British journal of pharmacology and chemotherapy (Br J Pharmacol Chemother) Vol. 13 Issue 1 Pg. 103-6 (Mar 1958) ISSN: 0366-0826 [Print] England
PMID	13523145 (Publication Type: Journal Article)
Chemical References	Bromides Imidazoles imidazole murexine Choline
Topics	Animals Bromides Cats Choline (analogs & derivatives) Dogs Felis Imidazoles Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!